Synthesis and Characterization of Potential Dimers of Gatifloxacin – an Antibacterial Drug

GARAGA, Srinivas; REDDY, Ambati V. RAGHAVA; PRABAHAR, Koilpillai Joseph; KORUPOLU, Raghu Babu; SANASI, Paul Douglas

doi:10.3797/scipharm.1212-21

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).

Article

18 February 2013

12 Pages

Synthesis and Characterization of Potential Dimers of Gatifloxacin – an Antibacterial Drug

and

Chemical Research and Development Department, Aurobindo Pharma Ltd, Survey No: 71&72, Indrakaran (V), Sangareddy (M), Medak Dist., Hyderabad – 502 329, Andhra Pradesh, India

Department of Engineering Chemistry, A. U. College of Engineering (A), Andhra University, Visakhapatnam – 530 003, Andhra Pradesh, India

Author to whom correspondence should be addressed.

Sci. Pharm.2013, 81(3), 651-662;https://doi.org/10.3797/scipharm.1212-21

Version Notes

Order Reprints

Abstract

Gatifloxacin is an antibacterial agent belonging to the fourth-generation fluoroquinolone family. Four piperazine-linked fluoroquinolone dimers of Gatifloxacin were observed during the laboratory process for Gatifloxacin and they were identified. The present work describes the origin, synthesis, characterization, and control of these dimers along with the synthesis of Despropylene Gatifloxacin (metabolite).

Keywords:

Gatifloxacin; Piperazine dimers; Synthesis; Characterization

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Synthesis and Biological Evaluation of Novel Alkyl-Imidazolyl Carbinols and their Esters: Potent Antimycotics

Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity